When PBMCs isolated from patients with active AIHA were stimulated with anti-IgM plus CD40L in the presence of an increasing dose of recombinant human IL-33 protein, we found that IL-33 could promote the production of IgG anti-RBC antibody in a dose dependent manner (Fig. 4a). This evidence concerns the gene CD40LG and autoimmune hemolytic anemia.